According to reports from Essential Business Intelligence, Apollo Hospitals Enterprise Ltd.'s managing director Suneeta Reddy stated on Monday that she does not think price caps are the right solutions to make healthcare more affordable. Instead, the company will reduce costs internally, removing up to 100 basis points. This strategic approach comes as the company continues its expansion plans, with a new facility opening in Gurgaon in the first week of November.
As reported by Essential Business Intelligence, this development follows a parliamentary panel's recommendation in August 2026 for making private healthcare more affordable. The panel has recommended that private hospitals publish their tariffs before admitting patients and proposed a fast-track ombudsman mechanism to audit excessive billing. In a significant GST recommendation, the panel called for healthcare services to be moved from the current 'GST exempt' regime to zero-rated GST at 0%, allowing hospitals to claim input tax credit on capital expenditure including medical equipment and infrastructure.
According to Essential Business Intelligence, Apollo Hospitals Enterprise Ltd. shares saw a 0.86% downturn to settle at ₹8,835.50 at the end of trading, compared to a 0.36% downturn of the NSE Nifty 50. The stock opened at ₹8,960.00 and moved in the range of ₹8,822.50 to ₹9,000.00 during the session. Looking at its last 52-week performance, the stock has touched a low of ₹6,696.50 and a high of ₹9,050.00, with the company's market capitalization standing at ₹1.12 lakh crore and a P/E ratio of 94.40.
As reported by Essential Business Intelligence, Apollo Hospitals delivered strong Q1 results with net profit up 34.2% to ₹581 crore versus ₹433 crore in the previous year, beating estimates of ₹555 crore. Revenue increased 20.6% to ₹7,044 crore compared to ₹5,842 crore, surpassing estimates of ₹6,890 crore. EBITDA rose 28.2% to ₹1,092 crore versus ₹852 crore, with EBITDA margin improving to 15.5% from 14.6% year-on-year. Healthcare services revenue grew 21.7% to ₹3,620 crore while digital health revenue increased 20.4% to ₹2,977 crore.
